SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10030283
Source:
http://linkedlifedata.com/resource/pubmed/id/10030283
Search
Subject
(
61
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0003241
,
umls-concept:C0018823
,
umls-concept:C0086418
,
umls-concept:C1257792
,
umls-concept:C2826293
pubmed:issue
3
pubmed:dateCreated
1999-3-11
pubmed:abstractText
Vascular endothelial cells are primary targets for injury during both cellular and humoral allograft rejection (AR). In cardiac transplantation, the role of humoral immunity in mediating AR has not been extensively characterized.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/1U01-A137313
,
http://linkedlifedata.com/resource/pubmed/grant/1U01-A140129
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/0132144
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Isoantibodies
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0041-1337
pubmed:author
pubmed-author:FitzRR
,
pubmed-author:FredrichRR
,
pubmed-author:FreimarkDD
,
pubmed-author:GaleraOO
,
pubmed-author:GalfayanKK
,
pubmed-author:JordanS CSC
,
pubmed-author:ToyodaMM
,
pubmed-author:TrentoAA
,
pubmed-author:YoungSS
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
67
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
385-91
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:10030283-Adolescent
,
pubmed-meshheading:10030283-Adult
,
pubmed-meshheading:10030283-Aged
,
pubmed-meshheading:10030283-Antibody Formation
,
pubmed-meshheading:10030283-Cells, Cultured
,
pubmed-meshheading:10030283-Endothelium, Vascular
,
pubmed-meshheading:10030283-Enzyme-Linked Immunosorbent Assay
,
pubmed-meshheading:10030283-Female
,
pubmed-meshheading:10030283-Follow-Up Studies
,
pubmed-meshheading:10030283-Graft Rejection
,
pubmed-meshheading:10030283-Graft Survival
,
pubmed-meshheading:10030283-Heart Transplantation
,
pubmed-meshheading:10030283-Humans
,
pubmed-meshheading:10030283-Immunity, Cellular
,
pubmed-meshheading:10030283-Isoantibodies
,
pubmed-meshheading:10030283-Male
,
pubmed-meshheading:10030283-Middle Aged
,
pubmed-meshheading:10030283-Reference Values
,
pubmed-meshheading:10030283-Time Factors
,
pubmed-meshheading:10030283-Umbilical Veins
pubmed:year
1999
pubmed:articleTitle
The clinical significance of antibodies to human vascular endothelial cells after cardiac transplantation.
pubmed:affiliation
Department of Pediatrics, Cedars-Sinai Medical Center/UCLA School of Medicine, Los Angeles, California 90048, USA.
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, U.S. Gov't, P.H.S.
,
Research Support, Non-U.S. Gov't